Ngoc-Lan T Le, DO
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Le’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$167,641 in 2024
Medicaid paid $167,641 for 2,008 billed services this clinician did in 2024, up to 73 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 258 | $164,270 |
| Return visit (30+ min) | 377 | $1,885 |
| Short return visit (20+ min) | 283 | $1,480 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $6 |
| Medication list documented in medical record (COA) | 550 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 527 | $0 |
| 2024 | 2,008 | 6 | 73 | $167,641 |
| 2023 | 2,324 | 14 | 63 | $242,513 |
| 2022 | 6,017 | 25 | 98 | $716,117 |
| 2021 | 8,111 | 23 | 127 | $1,077,650 |
| 2020 | 4,255 | 17 | 101 | $402,641 |
| 2019 | 3,868 | 22 | 89 | $342,198 |
| 2018 | 1,819 | 15 | 74 | $314,618 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 433 | $239,667 |
| Short return visit | 562 | $869 |
| Short return visit (20+ min) | 359 | $662 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 133 | $492 |
| Blood test, lipids (cholesterol and triglycerides) | 25 | $380 |
| Thyroid stimulating hormone (TSH) | 12 | $228 |
| HEPATIC FUNCTION PANEL | 13 | $85 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 48 | $80 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 125 | $50 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 62 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 229 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,274 | $701,864 |
| Short return visit | 1,368 | $2,714 |
| Short return visit (20+ min) | 1,017 | $2,372 |
| Blood test, lipids (cholesterol and triglycerides) | 91 | $1,381 |
| Measurement of vitamin D in serum | 55 | $1,355 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 331 | $1,268 |
| Thyroid stimulating hormone (TSH) | 66 | $1,257 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose | 15 | $600 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 15 | $600 |
| Hemoglobin A1C level | 54 | $594 |
| ELECTROLYTE PANEL | 61 | $483 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 54 | $476 |
2021
| Clinic visit/encounter, all-inclusive | 2,147 | $1,053,136 |
| Blood test, lipids (cholesterol and triglycerides) | 301 | $4,569 |
| Thyroid stimulating hormone (TSH) | 196 | $3,732 |
| Short return visit | 2,370 | $3,594 |
| Hemoglobin A1C level | 164 | $1,804 |
| HEPATIC FUNCTION PANEL | 263 | $1,593 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 37 | $1,480 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 37 | $1,480 |
| Short return visit (20+ min) | 1,081 | $1,409 |
| ELECTROLYTE PANEL | 156 | $1,239 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 30 | $1,200 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 135 | $1,191 |
2020
| Clinic visit/encounter, all-inclusive | 1,532 | $394,476 |
| Blood test, lipids (cholesterol and triglycerides) | 116 | $1,761 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 256 | $1,578 |
| Thyroid stimulating hormone (TSH) | 78 | $1,485 |
| Short return visit (20+ min) | 1,023 | $1,288 |
| Short return visit | 678 | $808 |
| HEPATIC FUNCTION PANEL | 69 | $296 |
| Hemoglobin A1C level | 26 | $286 |
| ELECTROLYTE PANEL | 26 | $207 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 17 | $150 |
| COMPREHENSIVE METABOLIC PANEL | 12 | $144 |
| Return visit (30+ min) | 130 | $81 |
2019
| Clinic visit/encounter, all-inclusive | 1,064 | $323,469 |
| Thyroid stimulating hormone (TSH) | 188 | $3,580 |
| Blood test, lipids (cholesterol and triglycerides) | 183 | $2,764 |
| Short return visit (20+ min) | 958 | $1,932 |
| HEPATITIS C ANTIBODY | 97 | $1,569 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 149 | $1,314 |
| Hepatitis B surface antibody (HBsAb) | 100 | $1,217 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 94 | $1,100 |
| Hemoglobin A1C level | 99 | $1,089 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 104 | $996 |
| Return visit (30+ min) | 293 | $757 |
| HEPATIC FUNCTION PANEL | 187 | $580 |
2018
| Clinic visit/encounter, all-inclusive | 998 | $310,400 |
| Short return visit (20+ min) | 331 | $913 |
| Return visit (30+ min) | 188 | $886 |
| Thyroid stimulating hormone (TSH) | 21 | $400 |
| Blood test, lipids (cholesterol and triglycerides) | 21 | $319 |
| HEPATITIS C ANTIBODY | 19 | $307 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 16 | $293 |
| IAAD IA HEPATITIS B SURFACE ANTIGEN | 20 | $234 |
| Hepatitis B surface antibody (HBsAb) | 19 | $231 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 20 | $192 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 18 | $159 |
| Hemoglobin A1C level | 13 | $143 |
Drugs they prescribed that Part D paid
$7,211
Pharmacies billed $7,211 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 359) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
334 generic and 25 brand-name prescriptions · $7,211 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 19 | $471 | $25 |
| Atorvastatin | 59 | $216 | $4 |
| Fluticasone Propionate | 16 | $137 | $9 |
| Lisinopril | 25 | $110 | $4 |
| Losartan | 26 | $104 | $4 |
See all 9 drugs
| Albuterol Sulfate Hfa | 19 | $471 | $25 |
| Atorvastatin | 59 | $216 | $4 |
| Fluticasone Propionate | 16 | $137 | $9 |
| Lisinopril | 25 | $110 | $4 |
| Losartan | 26 | $104 | $4 |
| Metformin | 23 | $93 | $4 |
| Tamsulosin | 19 | $92 | $5 |
| Alendronate | 17 | $69 | $4 |
| Amlodipine Besylate | 22 | $45 | $2 |
Year by year
| 2024 | 359 | 42 | 0% (0) | 7% | $7,211 |
| 2023 | 580 | 86 | 0% (0) | None | $19,857 |
| 2022 | 997 | 172 | 0% (0) | None | $33,404 |
| 2021 | 781 | 142 | 0% (0) | None | $18,608 |
| 2020 | 795 | 162 | None | None | $22,465 |
| 2019 | 601 | 136 | None | None | $14,841 |
| 2018 | 437 | 80 | 0% (0) | None | $7,651 |
| 2017 | 313 | 100 | 0% (0) | None | $10,497 |
| 2016 | 2,027 | 140 | None | 18% | $79,745 |
| 2015 | 2,143 | 155 | 1% (12) | 15% | $91,467 |
| 2014 | 1,358 | 151 | 1% (12) | 14% | $49,671 |
| 2013 | 836 | 54 | None | 19% | $18,128 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Atorvastatin | 84 | $1,350 | $16 |
| Albuterol Sulfate Hfa | 22 | $950 | $43 |
| Ventolin Hfa | 14 | $796 | $57 |
| Losartan | 46 | $685 | $15 |
| Metformin | 40 | $556 | $14 |
| Lisinopril | 29 | $504 | $17 |
| Alendronate | 26 | $432 | $17 |
| Fluticasone Propionate | 27 | $391 | $14 |
| Pravastatin | 24 | $385 | $16 |
| Metoprolol | 14 | $250 | $18 |
| Simvastatin | 20 | $243 | $12 |
| Amlodipine Besylate | 36 | $227 | $6 |
| Levothyroxine | 15 | $208 | $14 |
| Cyclobenzaprine | 12 | $200 | $17 |
| Tamsulosin | 19 | $163 | $9 |
| Sertraline | 12 | $45 | $4 |
2022: 22 drugs
| Eliquis | 12 | $6,859 | $572 |
| Albuterol Sulfate Hfa | 39 | $1,845 | $47 |
| Gabapentin | 29 | $734 | $25 |
| Atorvastatin | 84 | $729 | $9 |
| Levothyroxine | 60 | $654 | $11 |
| Fluticasone Propionate | 56 | $536 | $10 |
| Pravastatin | 25 | $505 | $20 |
| Metformin | 92 | $455 | $5 |
| Tamsulosin | 31 | $431 | $14 |
| Losartan | 55 | $416 | $8 |
| Amlodipine Besylate | 65 | $323 | $5 |
| Fenofibrate | 13 | $260 | $20 |
| Lisinopril | 26 | $247 | $10 |
| Baclofen | 27 | $237 | $9 |
| Simvastatin | 41 | $215 | $5 |
| Alendronate | 25 | $205 | $8 |
| Metoprolol | 23 | $193 | $8 |
| Ibuprofen | 26 | $114 | $4 |
| Fosinopril | 11 | $93 | $8 |
| Sertraline | 12 | $86 | $7 |
| Azithromycin | 11 | $60 | $5 |
| Hydrochlorothiazide | 12 | $48 | $4 |
2021: 16 drugs
| Atorvastatin | 76 | $776 | $10 |
| Levothyroxine | 61 | $725 | $12 |
| Albuterol Sulfate Hfa | 13 | $532 | $41 |
| Gabapentin | 20 | $437 | $22 |
| Fluticasone Propionate | 39 | $414 | $11 |
| Baclofen | 27 | $314 | $12 |
| Metformin | 68 | $301 | $4 |
| Pravastatin | 15 | $261 | $17 |
| Losartan | 44 | $258 | $6 |
| Simvastatin | 57 | $247 | $4 |
| Lisinopril | 28 | $236 | $8 |
| Fenofibrate | 11 | $217 | $20 |
| Amlodipine Besylate | 41 | $201 | $5 |
| Alendronate | 23 | $198 | $9 |
| Ibuprofen | 27 | $124 | $5 |
| Tamsulosin | 16 | $115 | $7 |
2020: 19 drugs
| Ventolin Hfa | 17 | $981 | $58 |
| Fluticasone Propionate | 56 | $616 | $11 |
| Atorvastatin | 89 | $589 | $7 |
| Losartan | 71 | $387 | $5 |
| Ofloxacin | 12 | $342 | $29 |
| Levothyroxine | 22 | $305 | $14 |
| Fenofibrate | 11 | $258 | $23 |
| Simvastatin | 46 | $148 | $3 |
| Tamsulosin | 25 | $143 | $6 |
| Baclofen | 18 | $131 | $7 |
| Gabapentin | 15 | $126 | $8 |
| Ibuprofen | 34 | $126 | $4 |
| Alendronate | 19 | $119 | $6 |
| Metformin | 29 | $116 | $4 |
| Amoxicillin | 21 | $100 | $5 |
| Metoprolol | 11 | $97 | $9 |
| Amlodipine Besylate | 29 | $89 | $3 |
| Sertraline | 24 | $65 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $37 | $3 |
2019: 14 drugs
| Fluticasone Propionate | 36 | $280 | $8 |
| Losartan | 47 | $220 | $5 |
| Gabapentin | 23 | $210 | $9 |
| Atorvastatin | 27 | $202 | $7 |
| Simvastatin | 52 | $189 | $4 |
| Metformin | 34 | $177 | $5 |
| Levothyroxine | 12 | $172 | $14 |
| Amlodipine Besylate | 47 | $155 | $3 |
| Ibuprofen | 37 | $154 | $4 |
| Lisinopril | 23 | $121 | $5 |
| Tamsulosin | 12 | $117 | $10 |
| Alendronate | 11 | $96 | $9 |
| Baclofen | 11 | $85 | $8 |
| Hydrochlorothiazide | 16 | $40 | $2 |
2018: 15 drugs
| Tamsulosin | 23 | $223 | $10 |
| Fluticasone Propionate | 26 | $214 | $8 |
| Levothyroxine | 17 | $206 | $12 |
| Metformin | 42 | $200 | $5 |
| Ibuprofen | 35 | $163 | $5 |
| Gabapentin | 11 | $149 | $14 |
| Losartan | 28 | $137 | $5 |
| Nifedipine Er | 12 | $113 | $9 |
| Atorvastatin | 18 | $111 | $6 |
| Simvastatin | 34 | $82 | $2 |
| Omeprazole | 11 | $60 | $5 |
| Amlodipine Besylate | 12 | $60 | $5 |
| Lisinopril | 24 | $59 | $2 |
| Hydrochlorothiazide | 26 | $57 | $2 |
| Glipizide | 19 | $54 | $3 |
2017: 8 drugs
| Fluticasone Propionate | 37 | $355 | $10 |
| Levothyroxine | 11 | $135 | $12 |
| Simvastatin | 31 | $117 | $4 |
| Ibuprofen | 23 | $85 | $4 |
| Hydrochlorothiazide | 19 | $61 | $3 |
| Amlodipine Besylate | 14 | $57 | $4 |
| Lisinopril | 20 | $44 | $2 |
| Glipizide | 11 | $37 | $3 |
2016: 36 drugs
| Januvia | 42 | $16,328 | $389 |
| Lantus | 42 | $13,049 | $311 |
| Lantus Solostar | 12 | $4,526 | $377 |
| Symbicort | 15 | $3,965 | $264 |
| Humalog | 12 | $3,178 | $265 |
| Fluticasone Propionate | 127 | $1,225 | $10 |
| Ventolin Hfa | 21 | $1,148 | $55 |
| Atorvastatin | 147 | $1,141 | $8 |
| Proair Hfa | 20 | $1,075 | $54 |
| Metoprolol | 41 | $1,070 | $26 |
| Tamsulosin | 48 | $930 | $19 |
| Levothyroxine | 57 | $816 | $14 |
| Hydrochlorothiazide | 117 | $742 | $6 |
| Simvastatin | 156 | $549 | $4 |
| Lisinopril | 145 | $523 | $4 |
| Omeprazole | 72 | $500 | $7 |
| Amlodipine Besylate | 93 | $404 | $4 |
| Diltiazem 24hr Er | 22 | $342 | $16 |
| Insulin | 20 | $338 | $17 |
| Ibuprofen | 56 | $297 | $5 |
| Gabapentin | 46 | $291 | $6 |
| Losartan | 68 | $291 | $4 |
| Allopurinol | 26 | $284 | $11 |
| Oxybutynin Chloride | 14 | $253 | $18 |
| Metformin | 57 | $232 | $4 |
| Montelukast | 18 | $155 | $9 |
| Propranolol | 11 | $152 | $14 |
| Clopidogrel | 30 | $141 | $5 |
| Metoprolol | 41 | $119 | $3 |
| Carvedilol | 33 | $117 | $4 |
| Alendronate | 15 | $115 | $8 |
| Naproxen | 19 | $97 | $5 |
| Furosemide | 34 | $92 | $3 |
| Glipizide | 35 | $70 | $2 |
| Benazepril | 11 | $65 | $6 |
| Losartan-Hydrochlorothiazide | 12 | $60 | $5 |
2015: 37 drugs
| Januvia | 49 | $21,409 | $437 |
| Lantus | 48 | $20,878 | $435 |
| Novolog | 15 | $4,207 | $280 |
| Fenofibrate | 11 | $1,340 | $122 |
| Fluticasone Propionate | 126 | $1,310 | $10 |
| Proair Hfa | 15 | $1,026 | $68 |
| Metoprolol | 60 | $1,000 | $17 |
| Tamsulosin | 24 | $956 | $40 |
| Levothyroxine | 65 | $896 | $14 |
| Simvastatin | 185 | $820 | $4 |
| Atorvastatin | 87 | $752 | $9 |
| Lisinopril | 179 | $740 | $4 |
| Isosorbide Dinitrate | 11 | $592 | $54 |
| Metformin | 111 | $489 | $4 |
| Omeprazole | 96 | $487 | $5 |
| Amlodipine Besylate | 101 | $486 | $5 |
| Fenofibrate | 15 | $434 | $29 |
| Hydrochlorothiazide | 103 | $397 | $4 |
| Gabapentin | 27 | $383 | $14 |
| Losartan | 80 | $334 | $4 |
| Ibuprofen | 54 | $328 | $6 |
| Insulin | 15 | $311 | $21 |
| Montelukast | 20 | $264 | $13 |
| Allopurinol | 30 | $255 | $8 |
| Glyburide | 13 | $246 | $19 |
| Clopidogrel | 36 | $228 | $6 |
| Oxybutynin Chloride | 12 | $167 | $14 |
| Potassium Chloride | 11 | $153 | $14 |
| Furosemide | 51 | $139 | $3 |
| Pantoprazole | 21 | $136 | $6 |
| Glipizide | 35 | $118 | $3 |
| Hydralazine | 12 | $96 | $8 |
| Ranitidine | 15 | $72 | $5 |
| Carvedilol | 14 | $54 | $4 |
| Metoprolol | 17 | $42 | $2 |
| Trazodone | 12 | $36 | $3 |
| Citalopram Hbr | 13 | $23 | $2 |
2014: 30 drugs
| Lantus | 31 | $10,953 | $353 |
| Januvia | 21 | $9,135 | $435 |
| Nexium | 11 | $2,669 | $243 |
| Fluticasone Propionate | 62 | $1,044 | $17 |
| Tamsulosin | 34 | $911 | $27 |
| Metoprolol | 42 | $889 | $21 |
| Isosorbide Dinitrate | 11 | $790 | $72 |
| Simvastatin | 123 | $641 | $5 |
| Lisinopril | 109 | $578 | $5 |
| Carbamazepine | 11 | $518 | $47 |
| Metformin | 81 | $505 | $6 |
| Levothyroxine | 36 | $489 | $14 |
| Hydrochlorothiazide | 82 | $416 | $5 |
| Amlodipine Besylate | 60 | $321 | $5 |
| Losartan | 42 | $306 | $7 |
| Gabapentin | 24 | $294 | $12 |
| Atorvastatin | 29 | $276 | $10 |
| Omeprazole | 23 | $181 | $8 |
| Ibuprofen | 33 | $181 | $5 |
| Enalapril Maleate | 11 | $153 | $14 |
| Hydralazine | 14 | $143 | $10 |
| Potassium Chloride | 11 | $142 | $13 |
| Azithromycin | 21 | $140 | $7 |
| Allopurinol | 24 | $113 | $5 |
| Glipizide | 29 | $111 | $4 |
| Furosemide | 28 | $92 | $3 |
| Ultra Comfort | 18 | $84 | $5 |
| Clopidogrel | 11 | $75 | $7 |
| Atenolol | 16 | $57 | $4 |
| Metoprolol | 11 | $28 | $3 |
2013: 19 drugs
| Lantus | 59 | $7,944 | $135 |
| Fluticasone Propionate | 50 | $887 | $18 |
| Lisinopril | 113 | $571 | $5 |
| Simvastatin | 84 | $506 | $6 |
| Tamsulosin | 35 | $457 | $13 |
| Metformin | 60 | $435 | $7 |
| Levothyroxine | 52 | $334 | $6 |
| Hydrochlorothiazide | 55 | $293 | $5 |
| Glyburide | 14 | $279 | $20 |
| Pravastatin | 24 | $241 | $10 |
| Glipizide | 38 | $227 | $6 |
| Losartan | 18 | $210 | $12 |
| Amlodipine Besylate | 26 | $183 | $7 |
| Ultra Comfort | 24 | $174 | $7 |
| Gemfibrozil | 11 | $145 | $13 |
| Benazepril | 13 | $102 | $8 |
| Sertraline | 12 | $74 | $6 |
| Ibuprofen | 14 | $68 | $5 |
| Allopurinol | 21 | $63 | $3 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2022 | 1 | 1 | None | $59 |
| 2019 | 1 | 1 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $125 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-09-10 | Wegovy | $125 |
See earlier years (2022, 2019)
2022: $59
| Boehringer Ingelheim Pharmaceuticals | None | $59 | 1 payment
|
2019: $41
| Boehringer Ingelheim Pharmaceuticals | None | $41 | 1 payment
|
Professional record
- NPI
- 1124195409
- Licence
- CA 20A 9709
- Trained
- New York College of Osteo Medicine of New York Institute of Technology, 2003
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 16878 Meekland Ave, # 16, San Lorenzo, CA, 94580
- NPI first listed
- 2006-11-29
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.